| 1 |
中国胃食管反流病共识意见专家组．中国胃食管反流病共识意见(2006·10三亚)[J]．中华内科杂志，2007，46(2)：170-173.
|
| 2 |
Pieramico O, Zanetti MV.Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study[J]. Dig Liver Dis, 2000, 32(7): 567-572.
|
| 3 |
Hong SJ, Kim SW.Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian Countries[J]. Gastroenterol Res Pract, 2015, 2015: 985249.
|
| 4 |
Ho KY, Chan YH, Kang JY.Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country[J]. Am J Gastroenterol, 2005, 100(9): 1923-1928.
|
| 5 |
Sugimoto M, Uotani T, Ichikawa H, et al.Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan[J]. Digestion, 2016, 93(1): 24-31.
|
| 6 |
Xie T, Cui X, Chen D, et al.Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease[J]. Eur J Gastroenterol Hepatol, 2013, 25(10): 1195-1205.
|
| 7 |
Qian B, Ma S, Shang L, et al.Effects of Helicobacter pylori eradication on gastroesophageal reflux disease[J]. Helicobacter, 2011, 16(4): 255-265.
|
| 8 |
Saad AM, Choudhary A, Bechtold ML.Effect of Helicobacter pylori treatment on gastroesophageal reflux disease(GERD): meta-analysis of randomized controlled trials[J]. Scand J Gastroenterol, 2012, 47(2): 129-135.
|
| 9 |
Hamada H, Haruma K, Mihara M, et al.Protective effect of ammonia against reflux esophagitis in rats[J]. Dig Dis Sci, 2001, 46(5): 976-980.
|
| 10 |
El-Omar EM, Oien K, El-Nujumi A, et al.Helicobacter pylori infection and chronic gastric acid hyposecretion[J]. Gastroenterology, 1997, 113(1): 15-24.
|
| 11 |
Thor PJ, Błaut U. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease[J]. J Physiol Pharmacol, 2006, 57(3): 81-90.
|
| 12 |
Slomiany BL, Slomiany A. Role of ghrelininduced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori[J]. Inflammopharmacology, 2011, 19(4): 197-204.
|
| 13 |
王吉耀，凃传涛．从循证医学的观点看幽门螺杆菌与胃食管反流病的关系[J]．中华医学杂志，2006，86(38)：2667-2669.
|
| 14 |
袁耀宗，邹多武，汤玉茗，等．胃食管反流病的蒙特利尔(Montreal)定义和分类——基于循证医学的全球共识[J]．中华消化杂志，2006，26(10)：686-689.
|
| 15 |
Neumann H, Mönkemüller K, Vieth M, Malfertheiner P. Chemoprevention of adenocarcinoma associated with Barrett′s esophagus: potential options[J]. Dig Dis, 2009, 27(1): 18-23.
|
| 16 |
Rubenstein JH, Shaheen NJ.Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma[J]. Gastroenterology, 2015, 149(2): 302-317.
|
| 17 |
黄俊星，陈卫昌．食管癌分子靶向治疗研究进展[J/CD]．中华消化病与影像杂志(电子版)，2013，3(1)：39-42.
|
| 18 |
Luther J, Owyang SY, Takeuchi T, et al.Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis[J]. Gut, 2011, 60(11): 1479-1486.
|
| 19 |
Corley DA, Kubo A, Levin TR, et al.Abdominal obesity and body mass index as risk factors for Barrett′s esophagus[J]. Gastroenterology, 2007, 133(1): 34-41.
|
| 20 |
Malnick SD, Melzer E, Attali M, et al.Helicobacter pylori: friend or foe？[J]World J Gastroenterol, 2014, 20(27): 8979-8985.
|
| 21 |
IARC Working Group.Schistosomes, liver flukes and Helicobacter pylori.IARC Working Group on the evaluation of carcinogenic risks to humans.Lyon, 7-14 June 1994[J]. IARC Monogr Eval Carcinog Risks Hum, 1994, 61: 1-241.
|
| 22 |
Wang Q, Yu C, Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis[J]. Helicobacter, 2013, 18(1): 41-53.
|
| 23 |
Herbarth O, Bauer M, Fritz GJ, et al.Helicobacter pylori colonisation and eczema[J]. J Epidemiol Community Health, 2007, 61(7): 638-640.
|